National Cancer Institute; Notice of Closed Meetings, 16317-16318 [E8-6094]

Download as PDF Federal Register / Vol. 73, No. 60 / Thursday, March 27, 2008 / Notices Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance Officer, Room 10–33, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. Written comments should be received within 60 days of this notice. Dated: March 20, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8–6224 Filed 3–26–08; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Clinical Center; Amended Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Notice is hereby given of a change in the meeting of the NIH Advisory Board for Clinical Research, March 31, 2008, 10 a.m. to March 31, 2008, 2 p.m., National Institutes of Health, Building 10, 10 Center Drive, Medical Board Room 2C116, Bethesda, MD 20892 which was published in the Federal Register on March 12, 2008, FR E8– 4654. There will not be a closed session for this meeting. The meeting is open to the public. Name of Committee: Center for Scientific Review Special Emphasis Panel; Trafficking. Date: April 16, 2008. Time: 3:30 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Joanne T. Fujii, PhD., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD 20892, (301) 435– 1178, fujiij@csr.nih.gov. Name of Committee: Oncological Sciences Integrated Review Group, Cancer Molecular Pathobiology Study Section. Date: May 19–20, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115. Contact Person: Elaine Sierra-Rivera, PhD., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 20892, 301–435– 1779, riverase@csr.nih.gov. BILLING CODE 4140–01–M pwalker on PROD1PC71 with NOTICES Name of Committee: Center for Scientific Review Special Emphasis, Panel Mechanism of Obesity and Diabetes. Date: April 16, 2008. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Reed A. Graves, PhD., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD 20892, (301) 402– 6297, gravesr@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846– 93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 19, 2008. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–6083 Filed 3–26–08; 8:45 am] Dated: March 18, 2008. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–6093 Filed 3–26–08; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M VerDate Aug<31>2005 16:08 Mar 26, 2008 Jkt 214001 16317 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 Dated: March 19, 2008. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–6095 Filed 3–26–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the President’s Cancer Panel, March 5, 2008, 1 p.m. to March 5, 2008, 3 p.m., National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852 which was published in the Federal Register on February 11, 2008, 73 FR7749. This meeting is amended to change the meeting date from March 5, 2008 to April 29, 2008. The meeting times will be 10 a.m. to 12 p.m. The meeting is closed to the public. Dated: March 19, 2008. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–6080 Filed 3–26–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice E:\FR\FM\27MRN1.SGM 27MRN1 16318 Federal Register / Vol. 73, No. 60 / Thursday, March 27, 2008 / Notices pwalker on PROD1PC71 with NOTICES is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; AIDS and Cancer Specimen Resource. Date: April 24, 2008. Time: 11 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Conference Room 611, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Sherwood Githens, PhD., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8053, Bethesda, MD 20892, 301/435–1822, githenss@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SPORE in Lymphoma and Lung Cancer. Date: June 9–10, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shamala K. Srinivas, PhD., Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892, 301–594–1224, ss537t@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SPORE in Prostate, Breast, Ovarian, Pancreatic and Gastrointestinal Cancers. Date: June 9–10, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Caron Lyman, PhD., Scientific Review Administrator, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive BIvd, Room 8119, Bethesda, MD 20892–8328, 301–451–4761, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Prevention, Control and Population Sciences. Date: June 11–12, 2008. Time: 5 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. VerDate Aug<31>2005 16:08 Mar 26, 2008 Jkt 214001 Place: Marriott Gaithersburg Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Wlodek Lopaczynski, MD, PhD., Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8131, Bethesda, MD 20892, 301–594–1402, lopacw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Clinical Studies P01 Special Emphasis Panel. Date: June 19–20, 2008. Time: 7 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Majed M. Hamawy, PhD., MBA, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8135, Bethesda, MD 20852, 301–594– 5659, mh101v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: March 17, 2008. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–6094 Filed 3–26–08; 8:45 am] BILLING CODE 4140–01–M Name of Committee: National Institute of General Medical Sciences, Special Emphasis Panel, Minority Biomedical Research Support in Neurology/Physiology. Date: March 31, 2008. Time: 8 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, 45 Center Drive, Room 3AN18, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Margaret J. Weidman, PhD., Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18B, Bethesda, MD 20892, 301– 594–3663, weidmanma@nigms.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821 Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: March 17, 2008. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–6085 Filed 3–26–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel To Review An Unsolicited P01. E:\FR\FM\27MRN1.SGM 27MRN1

Agencies

[Federal Register Volume 73, Number 60 (Thursday, March 27, 2008)]
[Notices]
[Pages 16317-16318]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-6094]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice

[[Page 16318]]

is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; AIDS and Cancer Specimen Resource.
    Date: April 24, 2008.
    Time: 11 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Conference Room 611, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Sherwood Githens, PhD., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd., Room 
8053, Bethesda, MD 20892, 301/435-1822, githenss@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Lymphoma and Lung Cancer.
    Date: June 9-10, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Shamala K. Srinivas, PhD., Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Boulevard, Room 8123, Bethesda, MD 20892, 301-594-1224, 
ss537t@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Prostate, Breast, Ovarian, Pancreatic and 
Gastrointestinal Cancers.
    Date: June 9-10, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Caron Lyman, PhD., Scientific Review 
Administrator, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive BIvd, Room 
8119, Bethesda, MD 20892-8328, 301-451-4761, lymanc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Prevention, Control and Population Sciences.
    Date: June 11-12, 2008.
    Time: 5 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Gaithersburg Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Wlodek Lopaczynski, MD, PhD., Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 8131, Bethesda, MD 20892, 301-594-1402, 
lopacw@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Studies P01 Special Emphasis Panel.
    Date: June 19-20, 2008.
    Time: 7 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Majed M. Hamawy, PhD., MBA, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8135, Bethesda, MD 20852, 301-594-5659, 
mh101v@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 17, 2008.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-6094 Filed 3-26-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.